Unit AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face Assignment Brief 2026

Unit AP707 Assignment Brief

Question 1

You are carrying out a consultation with Aisha, a client in her late thirties who is considering having procedures to treat her forehead and glabellar lines. During the consultation, Aisha explains to you that she follows strict religious practices and needs to know exactly what ingredients are found within the botulinum toxin type A products used in your clinic. She has concerns that some formulations may contain substances that go against her beliefs. She also asks you to explain clearly how the product works before she makes a final decision.

With reference to this scenario, discuss the types, composition, and pharmacological effects of the chemical compounds found in botulinum toxin type A solutions. Evaluate how Aisha’s religious beliefs may influence or prohibit her from undergoing the procedure, and explain how you, as the practitioner, should respond to ensure safe, ethical and culturally sensitive practice.

(minimum 500 words)
(total marks 20)

Question 2

Your client David is in his mid-forties; he presents with moderate glabellar lines and early lateral canthal (crow’s feet) rhytids. During the consultation and assessment, you identify that his procerus is overactive, but his medial corrugators are somewhat weak. You also note that he has a low-lying brow and slightly asymmetrical orbicularis oculi activity, the contraction on the right side being much stronger.

David asks you to explain how botulinum toxin type A will affect both the nearby and targeted facial muscle structures, and why you may need to adjust your injection technique, depth, and placement based on his anatomy.

With reference to the above scenario, explain the physiological effects of botulinum toxin type A on the targeted and surrounding facial muscles. In your answer, discuss why the injection technique, depth, and placement may need to be adapted for David and how these adaptations contribute to safe, effective, and aesthetic outcomes.

(minimum 500 words)
(total marks 20)

Question 3

Gemma is in her early fifties; she attends your clinic wanting to have botulinum toxin type A procedures for her deep forehead and glabellar lines. During her consultation, you learn the following information about her:

• Medical history: She has well-controlled hypertension and a history of migraines. 10 years ago, she suffered from Bell’s palsy on the left side of her face, but has no current symptoms.
• Medication: She takes beta-blockers for hypertension and has recently been prescribed a short course of antibiotics. She occasionally uses sumatriptan for migraine attacks.
• Previous aesthetic and dental history: 8 months ago, she had dermal fillers to the nasolabial folds and midface, and she has had regular anti-wrinkle injections in the past, although not within the last year. She has also had recent dental work including bruxism treatment, where she is required to use a night guard.
• Lifestyle factors: Gemma is a social smoker; she drinks alcohol most weekends and frequently attends high-intensity gym classes. She has a highly stressful job.
• Psychological and expectation factors: Gemma is unhappy with “looking tired and angry.” She wants her forehead to look “completely smooth at all times” and asks for “the strongest possible dose so that the results last longer.” She denies that she has any psychological conditions but appears preoccupied with minor imperfections.

With reference to the above scenario, explain the purpose, use, and limitations of botulinum toxin type A procedures in relation to the client’s past and current medical history, previous non-surgical cosmetic and dental procedures, lifestyle factors, contraindicated medication or medical conditions, psychological suitability, and procedure expectations. In your response, evaluate how each of these factors influences treatment planning, safety, and realistic outcomes.

(minimum 500 words)
(total marks 20)

Question 4

As an aesthetic practitioner you work in collaboration with an independent prescriber. Mikey, your client, who is in his late forties, comes to your clinic looking for treatment of his pronounced lateral canthal lines and subtle chin dimpling. During his consultation, you explain that botulinum toxin type A is a prescription-only medicine (POM) with specific licensed indicated uses. Mikey asks why some practitioners use it in other facial areas not mentioned in the product licence.

After assessing him and his face, you determine that his crow’s feet fall within licensed use, but treatment of his mentalis muscle (for chin dimpling) would be considered off-label. Before proceeding, you must justify your clinical decision to the prescriber and ensure that Mikey understands the purpose, limitations, and safety considerations.

With reference to the above scenario, explain the difference between licensed indicated use and off-label use of prescription-only medicines within aesthetic practice. In your answer, discuss when and why off-label use may be clinically appropriate, addressing considerations relating to client safety, treatment area, suitability, and the need for agreement from the regulated independent prescriber.

(minimum 500 words)
(total marks 20)

Question 5

You are getting ready to perform a botulinum toxin type A procedure for your client, Priya, who has informed you that she is particularly anxious about the potential discomfort she will experience while receiving the procedure. She requests that you apply a topical anaesthetic beforehand and asks whether it is safe and legally permitted.

Whilst carrying out your stock check, you realise that your current tube of licensed lidocaine-based topical anaesthetic has expired. Your colleague suggests that you use a high strength numbing cream that they previously purchased online from an overseas supplier. The product appears unlabelled and lacks clear concentration information.

Priya has also disclosed to you that she has a history of mild asthma and previous sensitivity to adhesive dressings. She understandably wants reassurance that the topical anaesthetic used will not cause an adverse reaction.

Before application, you must ensure that you are compliant with UK legislation on the sourcing, storage, and use of licensed topical anaesthetics within a botulinum toxin procedure.

With reference to the above scenario, explain the legislative requirements and restrictions for sourcing, storing and using licensed topical anaesthetics when preparing for a botulinum toxin type A procedure. In your answer, discuss legal supply routes, classification and concentration rules, secure storage and record-keeping requirements, practitioner responsibilities regarding safe application, and how these legal controls protect client safety.

(minimum 500 words)
(total marks 20)

Question 6

You are an aesthetic practitioner working in a busy medical-aesthetic clinic. You have a new client in their mid-forties, who has requested botulinum toxin type A procedures of their glabellar and forehead rhytids. It is your first appointment with them. The clinic has recently undergone a CQC audit, and your manager has emphasised the importance of strict compliance with health and safety legislation, infection-prevention policies, sharps handling regulations, and documentation standards.

During the consultation, you identify that the client takes several over-the-counter supplements, had dermal fillers six months ago, and has expressed to you their anxiety around needles. When preparing your treatment room, you notice another practitioner has left an unlabelled sharps bin half-full, and there are no visible cleaning records for the morning clinic. After the procedure, a staff member asks you to dispose of your treatment waste in a general waste bin due to a temporary shortage of clinical waste bags.

With reference to the above scenario, explain your legal and professional health and safety responsibilities before, during and after administering botulinum toxin type A. Your response should refer to relevant legislation, regulatory standards and clinic protocols, and consider infection prevention and control (IPC), safe use of prescription-only medicines, safe environment management, sharps safety, waste disposal, record keeping and post-procedure responsibilities.

(minimum 500 words)
(total marks 30)

Question 7

As an aesthetic practitioner, you work in an independent medical-aesthetic clinic. Your 40 year old client attends for elective botulinum toxin type A injections to the crow’s feet and glabellar region. It is their first time receiving any injectable cosmetic procedure. During the consultation, the client appears nervous and repeatedly asks if the results can be guaranteed. They disclose that they are hoping to look “more confident for an upcoming social event in two days.” You explain that full clinical effects will take longer, but the client seems distracted and asks to “sign quickly so we can start.”

At the time of the appointment, the prescriber who issued the prescription was off-site but had completed a remote video consultation earlier that morning. The clinic is busy, and your colleague reminds you that new clients must complete digital consent and medical history forms, plus photographic documentation, before the procedure. However, due to a technical issue, the digital consent platform is temporarily unavailable. They suggest obtaining only verbal consent and treating the client to “avoid delays.”

With reference to the above scenario, explain the legislative and indemnity requirements for gaining signed, informed consent before administering an elective botulinum toxin type A procedure. Your response should include the practitioner’s ethical, legal and professional responsibilities; prescriber requirements; documentation standards; the validity of consent; and the implications of failing to obtain compliant written informed consent.

(minimum 500 words)
(total marks 30)

Learning Outcomes and Assessment Criteria